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Abstract
Q fever, caused by Coxiella burnetii, may result in abortions in infected animals and pregnant women. However, the role that Q fever
plays in spontaneous abortions is still unknown. This study examined the association between Q fever serology and abortion in a region
where Q fever is endemic. A case–control population-based study was conducted in General Yagu¨e Hospital (Burgos area, Spain)
between June 2009 and July 2010. A total of 801 samples from 500 pregnant women were tested, of whom 273 had a spontaneous
abortion and 227 gave birth. IgG and IgM antibody titres against Q fever were determined in their two phases (I and II) by immunoﬂuo-
rescence assay. Seropositivity (phase I IgG ‡1:16 or phase II IgG ‡1:80) was detected in 88/273 (32.2%) cases and 53/227 (23.3%) con-
trols; p <0.01, OR 1.5, 95% CI 1.0–2.3. Seropositivity for both phases of IgG, compatible with recent or persistent infection, was
detected in 55 (20.1%) vs 22 (9.7%); p <0.001, OR 2.3, 95% CI 1.3–3.9. High phase II IgG antibodies compatible with active or recent
infection (titres ‡1:160) were detected in 27 (9.6%) vs 7 (3.1%); p <0.002, OR 3.4, 95% CI 1.4–8.0, respectively. Q fever was diagnosed
in 14 (5.1%) cases. The risk of abortion associated with serological markers of active or recent Q fever in pregnant women was mea-
surable and noticeable in this population, and accounted for 12% (95% CI 4–21%).
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Q fever is a worldwide zoonosis caused by Coxiella burnetii
[1]. Cattle and farm animals are the main reservoirs of the
microorganism [1–3]. Infected animals suffer from spontane-
ous abortions and other obstetric complications [3]. Humans
are mainly infected through inhalation of contaminated aero-
sols [1,2]. Q fever is usually an occupational disease,
although isolated cases and outbreaks have been reported in
people who have had indirect contact with infected animals
[1,2]. Acute Q fever has a wide clinical spectrum, although
the majority of cases are asymptomatic [1,2]. Endocarditis
represents the main complication of the chronic form [1,4].
Serology is the cornerstone of diagnosis and immunoﬂuores-
cence assay is the current reference method for the serodi-
agnosis of Q fever [5–7].
Spontaneous abortion affects 10–20% of pregnancies but
its cause remains unknown in more than 50% of cases [8].
There is currently no evidence that intrauterine infections
are signiﬁcantly associated with abortion in humans [9].
Fever data are available on the consequences of Q fever dur-
ing pregnancy. This infection acquired in the ﬁrst trimester is
a serious disease and frequently results in abortion [10–13].
In pregnant women and other mammals the bacteria will col-
onize and multiply in the uterus and placenta, and be reacti-
vated during subsequent pregnancies [11–15]. For this
reason, it is conceivable that active Q fever may be associ-
ated with abortion. However, the role that Q fever plays in
spontaneous abortions is still unknown.
The aim of the present study was to evaluate the relation-
ship between Q fever serology and spontaneous abortions
among women in a region where Q fever is endemic.
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A case–control population-based study was conducted in
General Yagu¨e Hospital (Burgos area, Spain) between June
2009 and July 2010 (13 months). A total of 2435 women
were admitted to our hospital for delivery at this time and
433 women having abortions (approximately 15% preva-
lence); from these, 273 having a spontaneous abortion
(cases) and 227 giving birth (controls) were enrolled in the
study. Our hospital is the only facility providing maternity
care to our health area (population about 220 000). The
study protocol was reviewed and approved by the hospital
Clinical Research Ethics Committee. All the women included
in the study signed an informed consent form.
Selection and classiﬁcation of patients
Both the control women and those with abortions were
selected at random, at a rate of about ﬁve per week in each
group. It was decided not to include women in the control
group with a previous complicated obstetrics history or
complicated partum because we do not know to what
degree an infection reactivated by Q fever inﬂuences these
aspects [10,12]. For this reason, and to make the control
group more representative, it was decided to exclude con-
trols with a current or previous complicated partum or
pregnancy. An intrauterine product of conception was con-
sidered as a pregnancy. Therefore, extrauterine pregnancies
were excluded. All miscarriages were conﬁrmed by ultra-
sound or pathological examination after uterine curettage.
According to the WHO a spontaneous abortion is ‘‘the
expulsion or extraction from its mother of an embryo or
foetus weighing 500 g or less’’ [16]. It typically corresponds
to a gestational age of 20–22 weeks or less [8]. The epidemi-
ological and clinical data were obtained using a personalized
questionnaire collected before the serology test results were
available. Past medical history was examined and patients
with relevant serology were contacted to collect additional
data and for follow-up. Contact with cattle was deﬁned as
habitual contact with farm animals (veterinarian, livestock
farmer, butcher, farm worker), consumption of uncontrolled
milk products, or contact with products from animal sources
or with animal manure [1,2]. Except for age, we did not ﬁnd
any risk factors common to being C. burnetii seropositive and
spontaneous abortion [8].
Serological and laboratory methods
Q fever IgM and IgG (phase I and II antigen) were deter-
mined by immunoﬂuorescence assay using reagents and test
protocols from Focus Technologies (formerly MRL, Cypress,
CA, USA). Blood samples were collected by venepuncture,
and serum samples were stored at )20C until analysis [6].
Titres equal to or greater than IgG II (1:80), IgG I (1:16), IgM
I (1:16) and IgM II (1:10), were considered positive. The ﬁrst
serological determination was performed after partum or
abortion (<48 h). In all cases a second sample was obtained
2 or 3 weeks after abortion. A second sample was obtained
from the controls at 2 or 3 weeks after partum when the ti-
tres were high (at least twice the threshold for seropositiv-
ity). Furthermore, in both cases and controls, at least one
more serology sample was obtained every 2–3 weeks from
the last serology performed if there were increased titres.
Our laboratory was not aware of the source of the samples
nor did it have any clinical information about them. Q fever
is deﬁned solely by serological criteria based on the frequent
asymptomatic nature of infection during pregnancy [10–13].
Post-abortion seroconversion, or a fourfold increase or
decrease in speciﬁc antibodies titres, was diagnostic of Q
fever [6,7]. We cannot exclude acute or recent infection
with high phase II IgG antibodies (titres ‡1:160) [7,17]. A
diagnosis of chronic Q fever was made with an IgG phase I
titre of ‡1:800 in at least two consecutive samples and a
speciﬁc chronic infectious syndrome [7]. In cases and con-
trols the following analyses were performed on one or more
occasions: white cell count, platelet count, general biochem-
istry parameters, liver enzymes, plasma coagulation, urine
sediment and analysis, C-reactive protein, erythrocyte sedi-
mentation count, white blood cell count and serology for
Toxoplasma gondii, Treponema pallidum, rubella virus, cytomeg-
alovirus, hepatitis B virus and human immunodeﬁciency virus.
Other serology was carried out in abortions in case of fever
or general clinical symptoms: herpes simplex viruses 1 and 2,
parvovirus B19, Brucella melitensis, Mycoplasma pneumoniae,
Epstein–Barr virus, Chlamydia pneumoniae, inﬂuenza viruses A
and B, adenovirus, respiratory syncytial virus and Legionella
pneumophila. Other diagnostic tests were performed at the
discretion of an experienced internist.
Statistical analysis
To determine the sample size, data obtained from a popula-
tion sample from southern France was used as a reference
(15% for phase II IgG >1:100) [17]. The Z-statistic was
applied for comparison of dichotomous variables, expecting
to observe an OR ‡2. Any OR with a conﬁdence interval
that excluded unity would be considered as clinically rele-
vant. If we assumed an a risk of 5% and a b risk of 10% and
given the one-sided character of the alternative hypothesis,
the minimum sample size was calculated to be 197 cases.
The collection of data was extended for a minimum period
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of 1 year to correct for possible seasonal bias of the primary
acute Q fever incidence peak [1,2]. All analyses were per-
formed using SPSS version 15.0 (SPSS Inc., Chicago, IL, USA).
Data were analysed using Fisher’s exact test or Mann–Whit-
ney U-test, depending on the type of variable. The ‘attribut-
able risk per cent’ in case–control studies was computed by
means of the Cole and MacMahon method [18]. A p value
<0.05 was considered to be statistically signiﬁcant. We
decided to use a one-sided p value as all the evidence points
to the directionality of this relationship only going one way.
Results
A total of 801 samples were tested; one sample was analysed
for 245 women and two or more for 255 women. Seventeen
women with abortions and 28 control women were previously
excluded because they did not sign the informed consent.
Patient characteristics and serological results are summarized
in Table 1. There was an association between IgG titres com-
patible with active or recent Q fever and spontaneous abor-
tion. Age, time of residence in Burgos, contact with cattle and
cohabitation with pets were also associated with abortion. In a
multivariate logistic regression adjusted for these variables,
spontaneous abortion (OR 3.4, 95% CI 1.4–8.1) and age (OR
1.7, 95% CI 1.2–2.5) remained associated with increased titres
for Coxiella. If the proportion of the population exposed (active
or recent Q fever) was 11.4% (Pe) and the estimated relative
risk was 2.3 (95% CI 1.41–3.52) (R), then the attributable risk
per cent (Ae%) of associated abortion [Ae% = Pe(R – 1)/1
+ Pe(R – 1) · 100] [18] was 12% (95% CI 4–21%).
We also took into account anembryonic pregnancies
(early abortions caused by chromosomal abnormalities in
about 90% of cases) and other possible causes of abortion
(Table 3) [16]. When studying just the 192 cases without
these characteristics, this association increases [24/192
(12.5%) vs 7/227 (3.1%); p <0.001, OR 4.5, 95% CI 1.8–10.6].
The same happened with those who had seropositivity for
both phases of IgG [41 (21.4%) vs 7 (3.1%); p <0.001, OR
2.5, 95% CI 1.4–4.5], and seropositivity for both phases of
IgG or high phase II IgG titres [45 (23.4%) vs 7 (3.1%);
p <0.001, OR 2.8, 95% CI 1.6–4.9].
There was a difference in distribution of phase II IgG titres
in the two study groups (Table 2). IgM antibodies were
observed in only one case of abortion. Q fever was diagnosed
in 14 (5.1%) cases: seroconverted (two women), fourfold
increase IgG titres (three womrn), fourfold decrease (eight
women). Two controls with initial high IgG titres also showed
signiﬁcant serological changes: one an increase and the other
a decrease. Only one woman with an abortion and high phase
II IgG titres suffered mild general symptoms. Two women
(one case and one control) had more than three consecutive
phase I IgG titres in the chronic Q fever range. However,
these patients remained asymptomatic and trans-thoracic and
trans-oesophageal ultrasonography as well as PCR assays of
their blood were negative. No seasonal trends were
observed in these women. We did not ﬁnd signiﬁcant differ-
ences in the frequency whether the abortions were early or
late (>12 weeks of gestation) as regards seropositivity.
Differences in white cell count (p 0.03) and C-reactive
protein values (p 0.005) between seropositive and seronega-
tive cases were detected (Table 3). On classifying by sub-
groups, these differences were independent from the
presence of other infections, fever, or general symptoms.
IgM antibodies were positive against Mycoplasma pneumoniae
in three women with abortions, and were positive in one
woman each against herpes simplex virus 1, herpes simplex
virus 2 and varicella zoster virus. One woman with abortion
TABLE 1. Patient characteristics and serological results of 500 pregnant women
Cases (n = 273) Controls (n = 227) p value OR 95% CI
Age (years) 34 (31–38) 32 (24–35) <0.001 – –
Time in Burgos (years) 28 (8–35) 25 (5–33) 0.01 – –
Born in Spain 226 (82.8) 183 (80.6) 0.56 1.1 0.7–1.8
Rural lifea 57 (20.9) 54 (23.6) 0.25 1.1 0.7–1.8
Caucasian ethnicity 240 (88.6) 194 (87.0) 0.34 1.1 0.6–1.9
Contact with cattle 31 (11.4) 13 (5.7) 0.01 2.1 1.0–4.1
Contact with pets 84 (30.8) 51 (22.5) 0.02 1.5 1.0–2.2
Serology
IgG I ‡16 or IgG II ‡80b 88 (32.2) 53 (23.3) 0.01 1.5 1.0–2.3
IgG I ‡16 and IgG II ‡80c 55 (20.1) 22 (9.7) 0.001 2.3 1.3–3.9
IgG II ‡160d 27 (9.9) 7 (3.1) 0.002 3.4 1.4–8.0
(IgG I ‡16 and IgG II ‡80) or IgG II ‡160 59 (21.6) 22 (9.7) 0.001 2.5 1.5–4.3
Quantitative variables expressed as median and interquartile range. Dichotomous variables expressed as n (%); Mann–Whitney U-test or Fisher’s exact chi-squared test (one-
sided), according to the type of variable; Cases, pregnant women with spontaneous abortion; Controls, pregnant women with no history of abortion or obstetric complica-
tions in the current pregnancy or previous pregnancies.
aPopulation <10 000 inhabitants.
bSeropositivity.
cSerological titres compatible with recent, persistent or recrudescent infection.
dAn active or recent infection cannot be excluded.
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suffered a symptomatic Escherichia coli urinary infection and
another had acute sinusitis caused by Haemophilus inﬂuenzae.
Discussion
This study demonstrates a strong association between sero-
logical titres consistent with acute or recent Q fever and
spontaneous abortion. This relationship is in agreement with
previous human observations. Spontaneous abortion was
observed in 13.5% of 53 [12] and seven of seven [10] preg-
nant women with ﬁrst-trimester untreated primary Q fever.
Some serosurvey studies in different populations have exam-
ined this association and found contradictory results. In
12 716 recently pregnant women in an area of France where
Q fever is endemic, seroprevalence of recent or chronic
infections was three times higher among women who had a
spontaneous abortion. However, the number of infected
women was too small and statistical signiﬁcance was not
achieved. In 438 women seen in a Recurrent Miscarriage
Clinic in London, no association was found between phase II
IgG titres ‡1:50 (4.6%) and miscarriage [19]. However, in
2394 subjects from Ireland, women with a history of miscar-
riage or prematurity were more often seropositive than
those without such a history (19.5% vs 9.8%, p <0.001) [20].
The absence of general symptoms in pregnant women
does not rule out an active infection in the presence of rele-
vant titres [10–12]. This was shown during an outbreak in
the French Alps, where only one out of 11 pregnant women
with Q fever had symptoms, compared with 48 out of 54
non-pregnant women [4]. We report an increased median
white blood cell count and C-reactive protein levels in
patients with positive serology. Despite being signiﬁcant, such
a difference is extremely limited and has no clinical rele-
vance. The increase in C-reactive protein was the only ana-
lytical marker that signiﬁcantly differentiated between
inpatients and outpatients with primary acute Q fever during
a large outbreak in the Netherlands [21]. However, all of
these patients had a C-reactive protein >10 mg/L.
Post-abortion serological changes were diagnostic of
active infection in 14 (5.1%) cases. However, the main path-
ogenic mechanisms involved in this association appear to be
related to a secondary or recrudescent infection [6]. This is
suggested by the absence of IgM antibodies [1,7] and the
high frequency of early seropositivity for both phases of
IgG [6]. This has been illustrated in a study with guinea-
pigs, where re-exposure to C. burnetii phase I (virulent)
105 days after the primary infection induced an early phase
I and II IgG antibody response [22]. Data related to the
intensity of the anamnesic immune response are contradic-
tory. In the previously mentioned experimental model, an
increase in phase II IgG antibodies was less than expected
[22]. The reactivation of Q fever as the result of pregnancy
in mice is also accompanied by little or no variation in
serological values [15]. However, after cardiac surgery in
humans there can be a signiﬁcant increase in IgG titres
compatible with reactive Q fever [23]. The low frequency
with which very high IgG II titres were found could indicate
TABLE 3. Characteristics of abortions to study according to






Age 34 (31–38) 34 (31–37) 0.33
Time in Burgos 30 (9–36) 25 (8–34) 0.19
Born in Spain 77 (87.5) 149 (80.5) 0.10
Rural lifea 21 (23.9) 36 (19.5) 0.24
Caucasian ethnicity 81 (93.1) 159 (86.4) 0.76
Contact with cattle 14 (15.9) 17 (9.2) 0.07
Contact with pets 27 (30.7) 57 (30.8) 0.55
Fever (>37C) 10 (11.4) 15 (8.2) 0.25
General symptomsb 10 (11.4) 41 (22.3) 0.02
Miscarriage late (>12 week) 6 (6.9) 16 (8.8) 0.39
Abortions (‡2) 23 (26.1) 59 (31.9) 0.51
Multiparity (‡2 births) 8 (9.1) 26 (14.1) 0.16
Pregnancies (‡2) 53 (60.2) 123 (66.8) 0.17
Anembryonic pregnancy 7 (8.0) 8 (4.3) 0.17
Concurrent causes of abortion 18 (20.5) 51 (27.6) 0.13
Endocrine pathology 5 (5.7) 17 (9.2) –
Anatomic abnormalities 3 (3.4) 9 (4.9) –
Neoplastic or autoimmune disease 3 (3.4) 14 (7.6) –
Others infections 4 (4.5) 4 (2.2) –
Invasive procedures and others 3 (3.4) 7 (3.7) –
Elevated liver enzymes 9 (10.2) 14 (7.6) 0.31
White blood cell count (·109/L),
median
8.3 (7.2–9.8) 7.6 (6.2–9.4) 0.03
Platelet counts (·109/L) 245 (60.1) 249 (55.7) 0.59
Sedimentation count (mm/h) 8 (5–11) 6 (4–10) 0.05
C-reactive protein (mg/L) 2 (0.5–4.5) 0.5 (0.5–3) 0.005
Quantitative variables expressed as median and interquartile range. Dichoto-
mous variables expressed as n (%); Mann–Whitney U-test or Fisher’s exact chi-
squared test (one-sided), according to the type of variable.
aPopulation <10 000 inhabitants.
bThe presence of at least three of the following in the 15 days before the mis-
carriage: fever (>37C), chills, muscle and/or joint pains, headaches, ﬂu-like
symptoms or weakness.
TABLE 2. Distribution of serological IgG titres against Coxi-
ella burnetii
Cases (n = 273) Controls (n = 227) p value
IgG phase I 0.18
<16a 206 (75.5) 189 (83.3)
16 42 (15.4) 28 (12.3)
32 11 (4.0) 6 (2.6)
64 9 (3.3) 2 (0.9)
128 2 (0.7) 0 (0.0)
256 2 (0.7) 1 (0.4)
512 0 (0.0) 1 (0.4)
1024 1 (0.4) 0 (0.0)
IgG phase II 0.009
<80a 203 (74.4) 189 (83.3)
80 43 (15.8) 31 (13.7)
160 14 (5.1) 3 (1.3)
320 7 (2.6) 1 (0.4)
640 5 (1.8) 3 (1.3)
1280 0 (0.0) 0 (0.0)
2560 1 (0.4) 0 (0.0)
Fisher’s exact chi-squared test (one-sided). Expressed as n (%).
aNegative titres.
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a mild immune response after infectious reactivation or
inhibition by a decrease in the infection load after miscar-
riage [6].
Isolation of bacteria is normally required to prove that
active infection did indeed occur. However, in this case it
could be difﬁcult, because this infection tends to be local
(intrauterine) and focal in these circumstances [5,12,13]. This
was illustrated in a Canadian study, where an association was
observed between seropositivity (291/7658) against C. burnet-
ii and previous or current neonatal death. However, no pla-
cental samples from 153 seropositive women showed signs
of Q fever by PCR [13]. In a French study, 21% (5/23) of
pregnant women with Q fever diagnosed by serology had
obstetric complications, but bacteria could not be identiﬁed
in any of them in the placenta or the fetus by PCR or cul-
ture [12]. However, in another series, all the women were
seropositive when Coxiella was identiﬁed (19/74) using PCR
in some of the many samples analysed, in both the mother
and the fetus [5]. In conclusion, bacterial isolation techniques
based on obtaining biological samples are of limited diagnos-
tic use, with serology being the best method for conﬁrming
the disease in pregnant women.
The validity of the results is demonstrated by the absence
of serological cross-reactivity with other zoonoses and com-
mon infections [19,24] and repeat samples in almost all
women with high titres [6,7]. The possible bias associated
with changes in the immune system during pregnancy virtu-
ally disappears with the control group used [25].
These results need to be conﬁrmed in other areas where
Q fever is endemic. It must be determined whether the
obstetric outcome of seropositive pregnant women with rel-
evant titres is changed with speciﬁc antibiotic therapy. It has
been shown that the administration of cotrimoxazole for
35 days to pregnant women with primary Q fever decreases
fetal mortality and placental infection [12]. In conclusion, our
results suggest that the association between Q fever and
spontaneous abortion is much higher than was thought. We
conﬁrm the need for serological monitoring of Q fever in
pregnant women from endemic areas [10,11].
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